As of Oct 12
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 80.00, with a high estimate of 89.00 and a low estimate of 58.00. The median estimate represents a +108.28% increase from the last price of 38.41.
The current consensus among 7 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.